Ginkgolide B Promotes Angiogenesis After Oxygen-Glucose Deprivation by Regulating AKT1 in bEnd.3 Cells
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl46724 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Yuanchen Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Chinese Medicine, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China. Hauptthemen laut MEDLINE: Ginkgolides, Proto-Oncogene Proteins c-akt, Glucose, Lactones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ischemic stroke leads to significant neuronal damage, and impaired angiogenesis remains a critical factor limiting post-stroke recovery. Ginkgolide B (GB), a key component of Ginkgo biloba extract, has shown potential neuroprotective effects, but its pro-angiogenic mechanisms remain unclear.
Methods
To investigate the effects of GB, we established an oxygen–glucose deprivation/reperfusion (OGD/R) model using bEnd.3 cells. Potential molecular targets of GB were explored through a combination of network pharmacology analysis, protein–protein interaction (PPI) network construction, pathway enrichment, and molecular dynamics simulations. Based on these predictions, a series of in vitro assays—including Cell Counting Kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU) incorporation, wound-healing, Transwell migration, and Matrigel tube formation tests—were performed to evaluate cell viability, proliferation, migration, and angiogenic activity. Western blotting was conducted to detect AKT serine/threonine kinase 1 (AKT1), vascular endothelial growth factor (VEGF), and Angiogenin (Ang) expression and clarify the role of the AKT1/VEGF/Ang pathway.
Results
Bioinformatics analysis identified 19 potential targets, among which AKT1, Matrix Metalloproteinase 9 (MMP9), and Prostaglandin-Endoperoxide Synthase 2 (PTGS2) exhibited the highest relevance. GB showed no evident cytotoxicity at concentrations up to 40 μM and mitigated the OGD/R-induced reduction in cell viability. At this concentration range, GB also enhanced endothelial proliferation, migration, and tube formation in bEnd.3 cells. Mechanistic studies revealed that MK2206 inhibition of AKT1 markedly suppressed AKT1 expression (p < 0.01), impaired angiogenic capacity, and aggravated ischemic–hypoxic injury, whereas GB treatment significantly increased VEGF and Ang expression (p < 0.01), likely via AKT1 upregulation (p < 0.01).
Conclusion
GB promotes angiogenesis and exerts neuroprotective effects by activating the AKT1/VEGF/Ang signaling pathway, suggesting its potential therapeutic value for ischemic stroke–related injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Chinese Medicine, Hunan University of Chinese Medicine, 410208 Changsha, Hunan, China.
- Department of Neurology, The First Affiliated Hospital of Hunan University of Chinese Medicine, 410006 Changsha, Hunan, China.
- The Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and Western Medicine, Hunan…
Zitieren
APA
Liao, Y., Luo, L., Ma, Q., Yan, S., He, M., Liu, L., Gao, X., Zhou, D., & Chen, Y. (2025). Ginkgolide B Promotes Angiogenesis After Oxygen-Glucose Deprivation by Regulating AKT1 in bEnd.3 Cells. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46724
Vancouver
Liao Y, Luo L, Ma Q, Yan S, He M, Liu L, et al. Ginkgolide B Promotes Angiogenesis After Oxygen-Glucose Deprivation by Regulating AKT1 in bEnd.3 Cells. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46724
BibTeX
@article{Liao2025,
author = {Liao, Yuanchen and Luo, Lei and Ma, Qiang and Yan, Siyang and He, Menghao and Liu, Lijuan and Gao, Xiaofeng and Zhou, Desheng and Chen, Yao},
title = {Ginkgolide B Promotes Angiogenesis After Oxygen-Glucose Deprivation by Regulating AKT1 in bEnd.3 Cells},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl46724}
}
EUVIMED